News

Ahn Ji-yong, head of the Joint Center at Seoul Bumin Hospital, published the results of a study that can predict the healing ...
Our Phase 1/2a clinical trial has demonstrated that the use of this stem cell population in humans is safe and effective in treating hard to heal diabetic foot ulcers." "We are extremely pleased ...
As the prevalence of chronic wounds continues to rise, so does the demand for specialized wound care. Conditions such as ...
More New Mexicans will be able to receive treatment for diabetic foot ulcers, thanks to a first-in-the-nation requirement for some health insurance plans to cover the costs. Gov. Michelle Lujan ...
Celularity (CELU) welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 2026, the effective date ...
The Center for Wound Healing utilizes a comprehensive clinical pathway for patients suffering from diabetic foot ulcers, pressure ulcers, infections and a variety of other chronic wounds.
Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSCs), reported today successful results of a Phase 1/2a clinical trial for treating ...